I. Castan-Laurell

发表

Apelin, a promising target for type 2 diabetes treatment?

I. Castan-Laurell, C. Dray, C. Knauf, 2012, Trends in Endocrinology & Metabolism.

Steatosis and insulin resistance: implication of hepatokines

I. Castan-Laurell, P. Valet, C. Bertrand, 2016 .

The apelin/APJ system as a therapeutic target in metabolic diseases

I. Castan-Laurell, P. Valet, B. Masri, 2019, Expert opinion on therapeutic targets.

Plasma Apelin and Risk of Type 2 Diabetes in a Cohort From the Community

M. Marre, R. Roussel, I. Castan-Laurell, 2019, Diabetes Care.

Apelin and energy metabolism

I. Castan-Laurell, P. Valet, C. Bertrand, 2015, Front. Physiol..

Apelin in Energy Metabolism

I. Castan-Laurell, P. Valet, 2011 .

Expanding role for the apelin/APJ system in physiopathology

F. Milagro, I. Castan-Laurell, C. Dray, 2007, Journal of Physiology and Biochemistry.

TNFα up‐regulates apelin expression in human and mouse adipose tissue

I. Castan-Laurell, C. Dray, P. Valet, 2006 .

Apelin, a novel adipokine over-produced in obesity: Friend or foe?

I. Castan-Laurell, C. Dray, P. Valet, 2005, Molecular and Cellular Endocrinology.

Caffeine reduces TNFα up-regulation in human adipose tissue primary culture

I. Castan-Laurell, C. Dray, P. Valet, 2007, Journal of Physiology and Biochemistry.

The therapeutic potentials of apelin in obesity-associated diseases

I. Castan-Laurell, C. Dray, P. Valet, 2021, Molecular and Cellular Endocrinology.

Sensitivity of cardiac carnitine palmitoyltransferase to malonyl-CoA is regulated by leptin: similarities with a model of endogenous hyperleptinemia.

I. Castan-Laurell, P. Valet, M. Gil-Ortega, 2010, Endocrinology.

Modifications of mesenteric adipose tissue during moderate experimental colitis in mice.

I. Castan-Laurell, P. Valet, V. Théodorou, 2014, Life sciences.

Regulation of Secreted Protein Acidic and Rich in Cysteine during Adipose Conversion and Adipose Tissue Hyperplasia

I. Castan-Laurell, P. Valet, E. Obberghen, 2006, Obesity.

Decreased resistin expression in mice with different sensitivities to a high-fat diet.

I. Castan-Laurell, P. Valet, P. Ferré, 2001, Biochemical and biophysical research communications.

Is Crohn's creeping fat an adipose tissue?

H. Guillou, I. Castan-Laurell, P. Valet, 2011, Inflammatory Bowel Diseases.

TNFalpha up-regulates apelin expression in human and mouse adipose tissue.

I. Castan-Laurell, C. Dray, P. Valet, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?

I. Castan-Laurell, C. Dray, P. Valet, 2022, Biomedicines.

Metabolic effects of apelin in human adipose tissue

I. Castan-Laurell, P. Valet, C. Attané, 2011 .

Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism

I. Castan-Laurell, P. Valet, J. Pradère, 2018, Endocrine.

Lipolysis is altered in MHC class I zinc-alpha(2)-glycoprotein deficient mice.

I. Castan-Laurell, P. Valet, S. Bahram, 2007, FEBS letters.

TNF (cid:1) up-regulates apelin expression in human and mouse adipose tissue

I. Castan-Laurell, C. Dray, P. Valet, 2006 .

Adipokine expression profile in adipocytes of different mouse models of obesity.

I. Castan-Laurell, P. Valet, J. Boucher, 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Effects of Dietary Eicosapentaenoic Acid (EPA) Supplementation in High-Fat Fed Mice on Lipid Metabolism and Apelin/APJ System in Skeletal Muscle

I. Castan-Laurell, P. Valet, Aurélie Batut, 2013, PloS one.

Understanding adipose tissue development from transgenic animal models.

I. Castan-Laurell, P. Valet, D. Langin, 2002, Journal of lipid research.

The transcriptional co-activator PGC-1α up regulates apelin in human and mouse adipocytes

I. Castan-Laurell, P. Valet, D. Langin, 2008, Regulatory Peptides.

Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine

I. Castan-Laurell, C. Dray, P. Valet, 2014, International Journal of Obesity.

Apelin, diabetes, and obesity

I. Castan-Laurell, C. Dray, C. Knauf, 2011, Endocrine.

Apelin, a newly identified adipokine up-regulated by insulin and obesity.

I. Castan-Laurell, P. Valet, J. Boucher, 2005, Endocrinology.

Apelin Treatment Increases Complete Fatty Acid Oxidation, Mitochondrial Oxidative Capacity, and Biogenesis in Muscle of Insulin-Resistant Mice

J. Penninger, I. Castan-Laurell, C. Dray, 2012, Diabetes.

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice.

I. Castan-Laurell, C. Dray, C. Knauf, 2008, Cell metabolism.

Apelin receptors: From signaling to antidiabetic strategy.

I. Castan-Laurell, C. Dray, C. Knauf, 2015, European journal of pharmacology.

Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.

Pascal G. P. Martin, J. Tanti, F. Bost, 2010, American journal of physiology. Endocrinology and metabolism.

The intestinal glucose-apelin cycle controls carbohydrate absorption in mice.

A. Nègre-Salvayre, B. Monsarrat, I. Castan-Laurell, 2013, Gastroenterology.

Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes

I. Castan-Laurell, C. Dray, O. Kunduzova, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic‐euglycaemic clamp

A. Sommet, I. Castan-Laurell, C. Dray, 2018, Diabetes, obesity & metabolism.

Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo.

I. Castan-Laurell, C. Dray, P. Valet, 2011, Journal of molecular endocrinology.

Lipolysis is altered in MHC class I zinc‐α2‐glycoprotein deficient mice

I. Castan-Laurell, P. Valet, S. Bahram, 2007 .

Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

Z. Kováčová, I. Castan-Laurell, C. Dray, 2008, European journal of endocrinology.

Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor

R. Schwabe, W. Wahli, H. Guillou, 2022, Science advances.

Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor

R. Schwabe, W. Wahli, H. Guillou, 2021, bioRxiv.

Human alpha 2A-adrenergic receptor gene expressed in transgenic mouse adipose tissue under the control of its regulatory elements.

B. Lowell, I. Castan-Laurell, P. Valet, 2002, Journal of molecular endocrinology.

Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice.

I. Leclercq, I. Castan-Laurell, C. Knauf, 2011, Antioxidants & redox signaling.

[The APJ receptor: a new therapeutic approach in diabetic treatment].

I. Castan-Laurell, C. Dray, C. Knauf, 2015, Medecine sciences : M/S.

Apelin Metabolic Functions

I. Castan-Laurell, C. Dray, C. Knauf, 2013 .

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice.

I. Castan-Laurell, C. Dray, C. Knauf, 2008, Cell metabolism.

Apelin, a newly identified adipokine up-regulated by insulin and obesity.

I. Castan-Laurell, P. Valet, J. Boucher, 2005, Endocrinology.

Is Crohn's creeping fat an adipose tissue?

H. Guillou, I. Castan-Laurell, P. Valet, 2011, Inflammatory bowel diseases.

Caffeine reduces TNFalpha up-regulation in human adipose tissue primary culture.

I. Castan-Laurell, C. Dray, P. Valet, 2007, Journal of physiology and biochemistry.

Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

Z. Kováčová, I. Castan-Laurell, C. Dray, 2008, European journal of endocrinology.

Effect of Hypocaloric Diet-induced Weight Loss in Obese Women on Plasma Apelin and Adipose Tissue Expression of Apelin and Apj

I. Castan-Laurell, C. Dray, V. Štich, 2009 .

Apelin receptors: From signaling to antidiabetic strategy.

I. Castan-Laurell, C. Dray, C. Knauf, 2015, European journal of pharmacology.